CFRI is pleased to welcome our new Chief Operating Officer, Dr. Mike Stonefield.
“I’m excited to be part of this world-class research organization,” says Dr. Stonefield. “I’m looking forward to working with everyone at CFRI and the broader research community as CFRI’s new strategic vision is put together and rolled out.”
A genetic discovery provides answers for families with a multisystem disease
Researchers have discovered mutations in a gene called NOTCH1 that causes Adams-Oliver syndrome (AOS), a rare and potentially fatal genetic disorder.
“These findings will allow clinicians to confirm the diagnosis of AOS more easily, as well as diagnose it in children who do not have all the usual symptoms,” says Dr. Millan Patel. “Our results will also open the door to developing therapies for some of the complications of the condition, which can be lethal in infancy or early childhood.” More…
Using innovative technology to improve care for vulnerable youth
CFRI Clinician Scientist Dr. Sandy Whitehouse recently attended TedMed 2014 in San Francisco to promote TickiT, an interactive tablet- or computer-based questionnaire designed to improve the way doctors collect information about their patients. More…
Fond Farewell: Dr. Janet Chantler
This October, the Diabetes Research Program at CFRI will be coming together to celebrate the retirement of one of its founding principal investigators, Dr. Janet Chantler.
After more than 40 years as a research virologist, Dr. Chantler leaves a lasting legacy as a scientist, mentor and valued colleague. Dr. Chantler is a CFRI Scientist and Professor with the UBC Department of Pathology.
Teenagers and young adults on the autism spectrum are needed for a new study investigating how people with autism process language. The study is being led by Dr. Anthony Bailey and conducted with the support of the Autism Research Group at CFRI. More…
Families with Weaver syndrome, doctors and scientists coming to Vancouver
The first International Conference on Weaver Syndrome will bring together families affected by Weaver syndrome and related overgrowth conditions along with the doctors, scientists and students who specialize in these rare disorders.